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Abstract
Background: Autoimmune diseases are disorders caused by an immune response directed against
the body's own organs, tissues and cells. In practice more than 80 clinically distinct diseases, among
them systemic lupus erythematosus and rheumatoid arthritis, are classified as autoimmune
diseases. Although their etiology is unclear these diseases share certain similarities at the molecular
level i.e. susceptibility regions on the chromosomes or the involvement of common genes. To gain
an overview of these related diseases it is not feasible to do a literary review but it requires
methods of automated analyses of the more than 500,000 Medline documents related to
autoimmune disorders.
Results: In this paper we present the first version of the Autoimmune Disease Database which to
our knowledge is the first comprehensive literature-based database covering all known or
suspected autoimmune diseases. This dynamically compiled database allows researchers to link
autoimmune diseases to the candidate genes or proteins through the use of named entity
recognition which identifies genes/proteins in the corresponding Medline abstracts. The
Autoimmune Disease Database covers 103 autoimmune disease concepts. This list was expanded
to include synonyms and spelling variants yielding a list of over 1,200 disease names. The current
version of the database provides links to 541,690 abstracts and over 5,000 unique genes/proteins.
Conclusion: The Autoimmune Disease Database provides the researcher with a tool to navigate
potential gene-disease relationships in Medline abstracts in the context of autoimmune diseases.
Background
Autoimmune diseases are commonly considered complex
immune disorders. While many autoimmune diseases are
rare, collectively these diseases afflict millions of patients.
According to [1] 5–8% of the US population suffers from
this group of chronic, debilitating diseases. Despite their
clinical diversity, they have one similarity, namely the
dysfunction of the immune system. It is suspected that
genetic defects play a role in the etiology of these diseases.
Modern high throughput technologies, like mRNA micro-
arrays, have enabled researchers to investigate diseases at
a genome-wide level. In contrast to classical inherited
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genetic diseases, like sickle cell anemia, autoimmune dis-
eases are not caused by the defect of a single gene, but by
the dysfunction of the complex interaction of a group of
genes. Although no autoimmune disease has been com-
pletely analysed, there has been tremendous success in
recent years in identifying major players in the develop-
ment of autoimmune diseases. In [2] there are over 50
publications that list gene variants that are associated with
a certain autoimmune disease. Interestingly, a lot of these
genes are located in the same regions on the chromo-
somes, the so called susceptibility regions. This has led to
a "common cause hypothesis" of autoimmune disorders.
Several organisations and institutes have established pro-
grams to investigate this common cause hypothesis,
among them the American Autoimmune Related Diseases
Association (AARDA) [3], the Autoimmune Diseases
Research Center at the Johns Hopkins Medical Institutes
[4], the Autoimmune Diseases Research Foundation
(ADRF) [5] and the Multiple Autoimmune Disease Genet-
ics Consortium (MADG) [6]. However, defects of one or
more of these genes do not cause an autoimmune disease,
but only predispose a person for an autoimmune disease.
The factors that trigger an autoimmune disease are still
unknown. Studies with monogenetic twins have revealed
that genetic influences only account for 25–40% of the
disease risk making gene environment interactions or
environmental influences the predominant factors. The
environmental influences are very diverse rendering
research in this area extremely difficult. These influences
may be toxic substances like mercury in one case and
ultraviolet light or even certain nutrients in another.
Moreover, several bacteria, viruses or hormones are
among the suspected triggers of autoimmune disorders.
In the post genomic era researchers are confronted with
the phenomenon that while the amount of accessible data
is growing exponentially, it is becoming harder and
harder to find the appropriate information. The number
of biomedical databases listed in the Nucleic Acids
Research 2005 Database Issue [7] has increased by 171 to
719. However, while information for entities like genes or
proteins can be found in databases like GenBank or Inter-
Pro, information about relations between entities is still
scarce. The main information source is still free text. In the
recent years, a lot of research has been done in the field of
information extraction and text-mining. State-of-the-art
systems are now able to recognise gene or protein names
with a precision between 80 – 95% and a corresponding
recall between 80 and 90% depending on the organism
[8]. In light of such capabilities it has become viable to use
these techniques in the compilation of databases. Several
projects are already using text-mining to support the
human experts that curate databases. For instance the
curation of the protein-protein interaction database BIND
[9] is supported by a program called PreBIND [10] and
the Molecular Interaction Database (MINT) [11] is sup-
ported by the MINT Assistant [12]. In these examples soft-
ware is utilised for information extraction by filtering
relevant documents and thus lowering the amount of
work for human experts. To cover the broad range of all
autoimmune diseases, we still deal with over 500,000
Medline abstracts, a number much to high for any human
expert to browse. We therefore opted for the compiling of
the database in a fully dynamic way. Using text-mining
allows the dynamic compilation of a database enabling
researchers to gain an overview of this extensive field.
In this paper we present a web-based database designed to
support researchers in the area of autoimmune diseases.
In the first section we will describe the design of the data-
base itself as well as the techniques used to compile the
database. Furthermore, the generation of comprehensive
synonym lists for the disease areas and the ProMiner sys-
tem [13] used for the recognition of protein and gene
names will be described. In the utility section we will
explain the content, different views and query capabilities
of our database. We also provide an evaluation of the
database content. In the discussion section we will briefly
review similar work in this area and address the unique
features of our system in particular.
Construction and content
The Autoimmune Disease Database (AIDB) [14] is a rela-
tional, integrated database that was dynamically com-
piled using dictionary based approaches for named entity
recognition of disease terms and protein and gene names.
For the autoimmune disease terms the Medical Subject
Headings (MeSH) [15] were used and additionally a dic-
tionary based on the Unified Medical Language System
(UMLS) [16] was developed. For the search every term in
the list was sent as query to the PubMed database [17].
The recognition of gene and protein names was based on
a named entity recognition system (ProMiner) which uses
a dictionary generated out of the Entrez Gene and Swiss-
Prot entries. Table 1 shows some statistics of the database
content.
The basic underlying concept behind the AIDB is that of
co-occurrences combined with statistical ranking between
disease terms and protein/gene names. Whereas we have
to accept a certain error rate due to the fact that the pure
mentioning of a disease in combination with recognised
gene and protein names does not imply a direct relation-
ship, this simple method allows us to gain a quick over-
view over a huge amount of abstracts and a high retrieval
rate concerning possible relationships. Hypothetic rela-
tions can be manually verified through the link to the rel-
evant text sources.BMC Bioinformatics 2006, 7:325 http://www.biomedcentral.com/1471-2105/7/325
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The Web-Presentation is designed using PHP and JavaS-
cript. For the storage of the data MySQL 4.0.13 is used.
Compilation of an autoimmune disease dictionary
The list of autoimmune diseases used in this database was
compiled from several sources, among them lists from the
American Autoimmune Related Diseases Association
(AARDA) [3], Johns Hopkins Autoimmune Diseases
Research Center [4] and MeSH. Some experts might disa-
gree whether one or the other of the listed diseases can be
really considered as an autoimmune disease. But this does
not harm our analysis. On the contrary, it could be inter-
esting to include other diseases like asthma or allergic dis-
eases which also share some similarities with
autoimmune diseases as pointed out in [18]. In the cur-
rent version of the AIDB we would like to concentrate on
the core list as defined above.
One problem that has to be tackled when applying text
mining techniques is synonymy. In the case of diseases,
there often exist different names for the same disease.
Looking only at certain names therefore gives an incom-
plete picture. We solve this problem by using the UMLS.
The UMLS is an umbrella system that unifies over 60 dis-
tinct clinical terminologies. The basic organisational unit
in the UMLS is a concept. Each concept has a concept
unique identifier (CUI). Other organisational units are
the string unique identifier (SUI) and the language unique
identifier (LUI) which are used to handle string variants
and language variants respectively. Each autoimmune dis-
ease is represented by a concept (and therefore by a CUI).
All known synonyms are linked to this concept. An exam-
ple is given in table 2. This table lists all synonyms for the
concept "Takayasu's Arteritis". This concept has 29 syno-
nyms or orthographic variants. A complete list of the
autoimmune disease concepts in the AIDB can be found
on the "Browse Disease" page [19]. The current version
contains 1,220 synonyms and orthographic variants for
103 concepts.
The usage of concepts as described above results in a
higher retrieval rate, in comparison to MeSH, the National
Library of Medicine's controlled vocabulary for indexing
Medline. There are 79 MeSH terms for autoimmune dis-
eases but 103 disease concepts extracted out of the UMLS.
But because the indexing is done by human experts the
quality of the assigned MeSH terms is quite high. Even if
the MeSH indexing can not be considered complete and
retrieve fewer matches, the usage of the MeSH terms
results in a higher precision.
Therefore we integrated two different search methods in
our system: the search of the whole disease synonym list
to increase the retrieval of matches and the use of MeSH
terms to have a higher certainty in respect to the recog-
nised disease terms. The database contains a table for dis-
ease concept-PMID links and a table for MeSH term-
PMID links. These tables are compiled using a Java Pro-
gram and the Entrez programming utilities [20]. In the
case of UMLS concepts, the program sends a query for
every term in the list to the PubMed database using the
"[tiab]" qualifier to restrict searches to "Title and
Abstract". In the case of MeSH terms, the list of MeSH
terms is used combined with a "[mesh]" qualifier result-
ing in a table of all PubMed abstracts indexed with an
autoimmune disease as MeSH term.
For the recognition of gene and protein names, which
raises many more recognition problems, we used an
already established software (ProMiner) [13] which is
briefly described in the next section.
Table 1: Statistics summarising the content of the Autoimmune Disease Database.
Parameter Value Description
N 2,661,938 # abstracts in all of Medline containing proteins/genes recognised by ProMiner
NDisease 401,128 # documents that mention at least one autoimmune disease in the title or abstract.
NDiseaseGene 85,425 # documents in NDisease containing a gene recognised by ProMiner
NMeSH 416,742 # documents that have an autoimmune disease as MeSH term
NMeSHGene 74,610 # documents in NMeSH containing a gene recognised by ProMiner
NAIDB 541,690 # documents union of subset NDisease and NMeSH
NAIDBGene 117,021 # documents in Ndisease and NMeSH containing a gene recognised by ProMiner
Ng 132,577 # protein/gene names recognised by ProMiner including synonyms and orthographic variants
Ngdiff 13,272 # different genes that are recognised by ProMiner in all of Medline
Ngaid 5,471 # genes in the subset related to autoimmune diseases NAIDBGene
MeSH terms 79 # MeSH terms in the context of autoimmune diseases
Concepts 103 # Concepts for autoimmune diseases
Statistics of the AIDB content. Note that the values shown in the table are from 6th of April 2006. The actual values may differ due to an update of 
the database.BMC Bioinformatics 2006, 7:325 http://www.biomedcentral.com/1471-2105/7/325
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Dictionary-based named entity recognition of gene and 
protein names in the ProMiner system
The ProMiner system consists of three different modules.
The first module covers the generation and curation of a
gene/protein name dictionary, which associates each bio-
logical entity with all known synonyms. The synonyms
are extracted out of the Entrez Gene database [21] and the
Swiss-Prot database [22]. As the name and synonym fields
in these databases often contain physical descriptions
(e.g. cDNA clone, RNA, 5'end), family names (e.g. mem-
brane protein) or other annotation remarks, the dictionary
is cleaned up by an automated process. Each synonym is
classified into one of several classes, which are associated
with specific parameter settings in the subsequent search
queries.
The second part of the system consists of an approximate
search procedure which is geared towards high recall and
accepts different parameter settings for each of the syno-
nym classes (e.g. search case sensitive or insensitive, with
or without permutations). This procedure is applied to
detect all potential name occurrences on the basis of the
constructed dictionary. Each synonym is treated as a string
of letters which can be split into several tokens. These
tokens generally correspond to words or numbers. For
instance, the string 'TGF-beta receptor type 3 precursor'
would be split into seven tokens: 'TGF', '-', 'beta',' recep-
tor', 'type', '3' 'precursor'. The detection problem is
addressed on the level of such tokens. Tokens are equiva-
lent if their strings match exactly. Depending on the
parameter the case of the strings has to match as well. Fur-
thermore, the set of all tokens is categorised according to
token classes which vary in significance for occurrence
detection. For the example above, the tokens "TGF",
"receptor", "3" are of higher relevance for a match than
the tokens "-", "type" or "precursor".
The search procedure works by browsing over the abstract,
processing one token at a time and keeping a set of candi-
date solutions for the respective position. Each candidate
solution is associated with two scoring measures. One
scoring measure, the boundary score, controls the end of
the extension of a candidate match and is increased on a
token mismatch. If this score rises above a defined thresh-
Table 2: UMLS concept Takayasu's arteritis.
Concept Synonym # PMIDs
Takayasu's Arteritis Takayasu's Arteritis MeSH 850
Takayasu's Disease 452
CUI: C0039263 Takayasu Arteritis 387
PULSELESS DISEASE MeSH 291
Aortic arch syndrome 246
TAKAYASU DISEASE 126
Nonspecific aortoarteritis 97
Atypical coarctation 73
Takayasu Syndrome 53
Middle aortic syndrome 40
Takayasu's syndrome MeSH 33
Primary arteritis 22
Nonspecific arteritis 22
Takayasu's arteriopathy 12
Idiopathic aortitis 8
Martorell syndrome 7
Aortic arch syndrome 5
ARTERITIS TAKAYASU 4
Aortic arch arteritis 3
Young female arteritis 2
BRACHIOCEPHALIC ISCHEMIA 2
TAKAYASUS ARTERITIS 1
Reverse coarctation 1
Idiopathic medial aortopathy and arteriopathy 1
TAKAYASU ARTERIOPATHY 0
Sclerosing aortitis and arteritis 0
Occlusive thromboarteriopathy 0
Raeder-Harbitz syndrome 0
Reversed coarctation syndrome 0
The concept "Takayasu's arteritis" and the synonyms for this concept as well as their occurrences in Medline. This concept has 29 synonyms and 
orthographic variants. The terms that are also listed in the MeSH vocabulary are indicated with "MeSH" in column 2. Note, that on the other 
extreme there are concepts with no synonym like "Psoriasis".BMC Bioinformatics 2006, 7:325 http://www.biomedcentral.com/1471-2105/7/325
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old, i.e. if a certain number of mismatches have occurred,
the candidate is pruned from the candidate set and
checked for reporting. Then, the second score measure,
the acceptance score, determines whether the candidate is
reported as a match. The acceptance score is a linear com-
bination of token class specific match- and mismatch
terms. A match term is defined as the percentage of
matched tokens of the respective token class. A mismatch
term counts for each token class the number of tokens
additionally found in the text and, thus, mismatched in
the candidate synonym. With appropriate weighting, the
acceptance score allows to accept variations of synonyms
and, at the same time, disregard false substring matches.
In such a way the approximate search strategy in ProMiner
allows for the recognition of different spelling variants of
dictionary entries in text.
In a last step, filters are applied to increase specificity of
the search results. The disambiguation filter attempts to
resolve ambiguous matches. This is important for the res-
olution of overlapping matches (e.g. the protein name
'TGF' should not match 'TGF receptor') but also to accept
only unique matches in the case of ambiguous terms. A
match is called unique if the match in the text could be
associated only to one Entrez Gene entry. If two or more
different gene entries share a synonym (e.g. LPS is used as
synonym for the Entrez Gene entries 3664 and 7452) the
system only accepts the match for the gene entry if it finds
another synonym for the same gene entry in the text (e.g
it would additionally find IRF6 for Entrez Gene entry
3664). A synonym might also be ambiguous because it is
an acronym used in different contexts (e.g. LPS is mostly
used as an acronym for lipopolysaccharide). Here names
from acronym dictionaries are additionally detected in the
text to resolve these ambiguities.
The ProMiner system was recently tested in the BioCreA-
tIvE assessment for the detection of gene and protein
names [23] for the organisms mouse, fly and yeast. The
ProMiner systems achieved the best performance in F-
score for mouse (0.79) and fly (0.81), and for yeast the
second best (0.9) (cf. table 3). For human we created our
own benchmark set with 250 annotated abstracts and
reach similar performance (F-score = 0.84, cf. table 3). In
the BioCreAtIvE assessment we also tested to accept
matches for non-unique gene and protein names. Here a
recognised name in the text could be matched to up to
three different gene entries if the recognised synonym is
associated with these entries. It was shown that we get
higher recall but at the same time lose precision and also
overall performance in F-score (cf. table 3, fly, accept
matches of synonyms associated with up to 3 different
Entrez Gene entries). For AIDB we therefore chose to
accept only unique matches.
Utility
The aim of the AIDB is to provide the researcher with a
quick overview of potential links between genes/proteins
and autoimmune diseases. The AIDB can be searched
through a web interface at [14]. There are two main start-
ing points for searching the database depending on the
question the user tries to answer. The user can either
browse the list of disease concepts or MeSH terms, or use
the search box in the top left corner to search for disease
terms or genes of interest. These two scenarios are
described in detail below.
Disease queries
Disease queries are either initiated on the "Browse by dis-
ease" page or on the "Browse by MeSH term" page. The
difference lies in the construction of the underlying asso-
ciation tables. For the disease link we have searched the
title and abstract of all Medline abstracts for the disease
terms using the PubMed search interface. For the gene-
MeSH term links we searched the MeSH entries for the
abstracts using the PubMed search interface. The reason
for this distinction is that not all autoimmune diseases are
listed as MeSH terms. Furthermore not all abstracts are
Table 3: Performance of the ProMiner system.
Organism Precision Recall F-score
Mouse 0.77 0.81 0.79
Yeast 0.97 0.84 0.90
Fly 0.83 0.80 0.82
Fly
Accept matches of synonyms 
associated to up to 3 different 
Entrez Gene entries
0.74 0.83 0.79
Human 0.86 0.81 0.84
The performance of the ProMiner system for the organisms fly, mouse and yeast was evaluated in the BioCreAtIvE assessment. For the human 
dictionary we annotated a corpus of 250 abstracts which served as reference corpus to determine recall, precision and F-score. All names are only 
matched to a gene entry if the recognised synonym is associated only to one gene entry in the corresponding dictionary (called unique matches). 
Only for the fly organism BioCreAtIvE results with different parameter setting are visualised (c.f. 4th row). Here a recognised name in the text could 
be matched to up to three different gene entries if the recognised synonym is associated with theses entries.BMC Bioinformatics 2006, 7:325 http://www.biomedcentral.com/1471-2105/7/325
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Disease query for the MeSH term Grave's disease Figure 1
Disease query for the MeSH term Grave's disease. Screen shot for the MeSH term "Graves' disease". The first column 
(Gene) contains the gene name. Moving with the mouse over the gene name shows the synonyms in a tool-tip. Clicking on the 
gene name initiates a search for this gene in the concept space. The second column contains the RANK coefficient, the third 
column the number of corresponding PMIDs and the forth column contains a pull-down menu containing the PMIDs. Like in 
the Concept view it is possible to link to the PubMed abstracts via the "Go" or the "LIST" button showing the abstract corre-
sponding to the actual PMID or all abstracts respectively. The last column contains links to Entrez Gene, Ensembl and Swiss-
Prot for further information about the current gene or protein.BMC Bioinformatics 2006, 7:325 http://www.biomedcentral.com/1471-2105/7/325
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Result for the search of the string "*neuropathy*" Figure 2
Result for the search of the string "*neuropathy*". Screen shot for the search of the string "*neuropathy*". In the first 
section all genes are listed that contain the search string. The search term is highlighted in green. The following two sections 
show the matching MeSH terms and disease concepts respectively.BMC Bioinformatics 2006, 7:325 http://www.biomedcentral.com/1471-2105/7/325
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Gene query for the Gene TNF Figure 3
Gene query for the Gene TNF. Screen shot for a gene query for the gene TNF. All autoimmune concepts and disease 
names that co-occur with TNF or one of its synonyms are listed on the page. Each line corresponds to a concept or disease. 
The second column shows the number of corresponding PMIDs indicating how frequent the terms are co-mentioned. The last 
column contains all PMIDs in a drop down list. Pressing the "Go" button links to the original abstract in the PubMed database 
of the PMID currently shown in the drop down list. Pressing the "List" button opens a new window containing all abstracts 
contained in the drop down list.BMC Bioinformatics 2006, 7:325 http://www.biomedcentral.com/1471-2105/7/325
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indexed. These abstracts are covered in the disease view.
The whole corpus of Medline abstracts that mention an
autoimmune disease or are indexed with an autoimmune
disease as MeSH term consists of 541,690 entries. 52% of
these abstracts have both an autoimmune disease as
MeSH and a concept in the free text. But 23% only have a
disease name in the abstract, and 25% only have a MeSH
term. As the views are very similar, we only show the
MeSH view here. Figure 1 shows a screen shot for the
search of all genes found for "Graves' disease" sorted
descending by number of PMIDs. The user has now the
option to either directly go to the reference for each gene
shown in the drop down list in the third column by press-
ing the "Go" button, or to browse the whole list of refer-
ences by pressing the "List" button. When pressing the
"List" button the complete list of references is presented as
sorted by publication date. Disease terms and recognised
gene or protein names are highlighted in the abstracts to
support a quick understanding of the described gene-dis-
ease association. In the last column three links are pro-
vided: Entrez Gene, Ensembl and Swiss-Prot. With these
links, the user can obtain a detailed overview of the spe-
cific gene or protein of interest.
Furthermore the search box in the upper left corner can be
used to search for disease concepts, MeSH terms or genes.
Wildcards may be used if the user does not know the exact
term. Figure 2 shows the result for the query "*neuropa-
thy*".
Gene queries
For a gene query the user types a gene name or gene sym-
bol into the search box. The database maintains a list of
gene symbols or official names as standardised by the
HUGO Gene Nomenclature Committee (HGNC) [24].
There is also a list of synonyms for each gene or protein. If
we do not have an official name or a synonym, the Entrez
Gene identifier is used. Additionally we provide the
names as they are used in the PubMed abstracts. If the user
moves the mouse over a gene symbol, a list of alternative
symbols and names is shown in a tool-tip box. After the
user initiates the search the gene name and synonym
tables are searched and the user is provided with a list of
matches. The user is then provided with an option to
browse the list of associated disease concepts or MeSH
terms by pressing on the "disease" or "MeSH term" button
respectively. Figure 3 shows a list of all autoimmune dis-
eases that co-occur in a PubMed abstract for the gene
"TNF" after pressing the "disease" button. If no gene-dis-
ease association is recorded for this gene in the AIDB this
view will not show up.
Measuring the relevance of gene-disease links
Given the high number of gene-disease links for most of
the disease concepts it is highly desirable to have some
kind of measure to evaluate the relevance of the different
genes to a particular disease. We have implemented three
methods (GENE, PMID, RANK) to sort the list of genes.
The first method allows to sort the gene names alphabeti-
cally (GENE). The second method is based on the fre-
quency of the genes in the context of the considered
disease. Genes are listed according to the number of co-
occurrences with a disease in PubMed references (PMID).
The third method (RANK) calculates a relevance score as
described below. This method was introduced in [25] to
measure the relevance of gene-to-disease links. In the fol-
lowing we explain how we applied this method in the
context of autoimmune diseases.
In brief, the method allows measuring the strength of the
relationship between a protein and a disease by analysing
how much the observed number of "protein documents"
deviates from the expected number if the draw had been
random. To illustrate the method we give an example for
IL4 in the context of insulin-dependent diabetes mellitus
(IDDM).
First we define the Set S which consists of all Medline
abstracts that contain a gene or protein name that was rec-
ognised by the ProMiner software. N is the number of all
documents in this set and nIL4 is the number of abstracts
where IL4 is mentioned. With these two figures we can cal-
culate the probability (1) of the occurrence of the term IL4
in a document of this set.
The subset s is defined as the set of documents that men-
tion IDDM in the abstract. With NIDDM as the number of
documents in this set we can calculate the expected value
(2) of IL4 mentions
E[nIL4_IDDM] = NIDDM * pIL4   (2)
The standard deviation is given by (3)
The strength of the relationship (4) is then measured by
including the real number of occurrences of IL4 in NIDDM
(nIL4_IDDM) in the following equation
With N = 2,661,938; nIL4 = 20,660; nIL4_IDDM = 208 and
NIDDM = 24,496 we get cIL4 = 1.001.
p
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Coefficients c with high absolute values indicate poten-
tially interesting candidate genes, whereby positive coeffi-
cients indicate genes mentioned more frequently than
expected (2) and negative coefficients indicate rarely pub-
lished genes in respect to the expected value. For example,
the values for coefficients in multiple sclerosis (MS) range
between [-28,9] and for Graves' disease between [-18,15].
The corresponding p-value for a coefficient of 15 as the
maximum coefficient for Graves' disease is 3.67 E-51
meaning that the probability to find a coefficient with a
higher value converges zero.
Top 50 genes view
The "Top 50 genes" view is a "hit-list" of genes in the con-
text of all considered autoimmune diseases [26]. This
does, however, not imply that these are the most impor-
tant genes. It merely shows the most published and ana-
lysed genes. But again if we apply our ranking coefficient
c (4) we get a measure for the strength of the correlation
to autoimmune diseases. The coefficient c is calculated in
the same way as above except that for the subset s we con-
sider all documents in the AIDB. We have analysed the top
50 genes in the AIDB and calculated precision and recall
through random sampling because it was not feasible to
evaluate each reference. In such a way we estimated a pre-
cision for gene recognition of 88% for the RANK method
and 90% for the frequency based method (cf. table 4, col-
umn 4). Errors for false recognition include disease names
that are also synonyms for genes (IDDM2, IgA-Nephrop-
athy), erroneous linking of cell type names to genes
(CD8A), or ambiguous names in the dictionary (ACR,
PLF).
Intersection of gene sets
Intersections of gene sets for different disease concepts are
of particular interest. It is widely recognised that persons
having one autoimmune disease have an increased sus-
ceptibility to other autoimmune disorders. E.g. the
MADGC [6] collects information about persons or fami-
lies that suffer from more than one autoimmune disorder
to understand the genes that autoimmune diseases have
in common. This has motivated us to provide an interface
where intersections of gene sets for different disease con-
cepts can be compiled. For both views, the concept-based
view and the MeSH-based view there is the possibility to
build these intersections. The intersection interface is
located at the bottom of the "Browse by Disease" page and
the "Browse by MeSH Term" page respectively [27,28]. A
link to the intersection interface is provided at the top of
each page to guide the user directly to the interface at the
bottom of the page. Two different concepts or MeSH
terms can be chosen from a drop-down list. As a result the
subset of genes is presented that has co-occurrences with
both disease concepts. Searching e.g. the disease term
"autoimmune lymphoproliferative" reveals 155 abstracts
and 67 genes, searching for "Crohn's disease" reveals
18,137 abstracts and 1,031 genes. Using the intersection
mode of the database we could find that almost all genes
that co-occur with autoimmune lymphoproliferative (#
57) also occur together with Crohn's disease. Another
example is the search for "autoimmune hearing loss".
Some of the listed genes are well known in the context of
other autoimmune diseases (e.g. HSPA1A and TNFSF5 co-
mentioned with over 24 and 70 of the other autoimmune
diseases, respectively).
Table 4: Assessment of the "Top 50 genes" page.
# Gene-Disease 
Associations in 
GAD
# correct Gene-
Disease 
Associations not in 
GAD
# False Recognition Precision of Gene 
Recognition
Examples False 
Recognition
RANK based 
method
35 9 6 88% (44/50) IDDM2 (insulin 
dependent diabetes 
mellitus type II)
CD8A (CD8-Cells)
IgAN (IgA-
Nephropathy)
ACR (Albumin-To-
Creatinine-Ratio)
Frequency based 
method
34 11 5 90% (45/50) IDDM2 (insulin 
dependent diabetes 
mellitus type II)
CD8A (CD8-Cells)
PLF (Pulmonary 
function)
The top 50 genes from the AIDB were evaluated in comparison to GAD (# genes found in GAD, correct genes not found in GAD and falsely 
recognised genes). The resulting precision of gene recognition is 88% for the RANK based method and 90% for the frequency based method. 
Erroneously recognised genes are listed in the last column.BMC Bioinformatics 2006, 7:325 http://www.biomedcentral.com/1471-2105/7/325
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Evaluation of the database
Given the large number of disease concepts and related
genes, a full evaluation of the database is not feasible.
However, to provide an evaluation of the system we have
selected several diseases which we would like to use for
evaluation. We try to answer the following questions: To
what extent are we getting the correct documents? To what
extent does the co-occurrence approach reveal important
links? How does the concept view compare to the MeSH
view? A formal evaluation of the gene and protein name
recognition performance is not presented here because it
was already done in the BioCreAtIvE assessment (see
above).
As reference corpus we used the Genetic Association Data-
base (GAD) [29], a manually curated database about
genetic associations. All entries in this database have been
edited by domain experts. The datasets therefore provide
an excellent baseline for evaluating our system.
The evaluation process is as follows: We selected two dis-
eases (multiple sclerosis and Graves' disease) that have a
sufficient high number of genes in both databases. Addi-
tionally we randomly selected 10 more diseases for evalu-
ation. In the first test we only checked to what extent our
database contains the gene-disease associations listed in
the GAD. We could show that we retrieved 84% of all
gene-disease associations for multiple sclerosis and 100%
for Graves' disease (cf. table 5, 1st and 2nd column). For
rheumatoid arthritis (RA) and systemic lupus erythemato-
sus (SLE) we yield comparable results (RA: 80%, SLE 82%
for the gene disease associations; data not shown). For the
other 10 diseases the precision is between 66% and 100%
yielding an average of 91% for all 12 considered diseases.
In the second test we checked to what extent we also
retrieved the same PubMed references as listed in GAD
(table 5, 3rd and 4th column). Here the concept-based and
the MeSH-based searches do not differ (data for MeSH not
shown). The recall here is 73% for multiple sclerosis and
66% for Graves' disease. The lower values are mainly due
to the fact that the HLA genes are not recognised ade-
quately. There is no clear naming convention for HLA
genes rendering correct recognition difficult for NER sys-
tems (e.g. HLA-DRB1 is often written as DR1). If we
exclude the HLA genes the recall will be 77% for multiple
sclerosis and 79% for Graves' disease. For the randomly
selected diseases the retrieval rate varies between 38%
(myasthenia gravis) and 100% (Addison's disease). The
bad result for myasthenia gravis is due to the fact that 3 of
the 5 genes ("acetylcholine receptor alpha subunit",
"AChR" and "AChR beta subunit") are not recognised by
ProMiner. The good result for Addison's disease is due to
the fact that only 2 genes are in GAD. The average for the
retrieval rate taking all 12 diseases into account yields
78%. For detailed results of these tests see Additional file
1 (MS and Graves' disease) and Additional file 2 (for the
randomly selected diseases).
The error analysis (cf. table 6) shows that the lower recall
is mainly based on the missing recognition of gene and
protein names (around 67%) and only to a minor degree
(27%) due to missing disease recognition. Lacking dic-
tionary names are one main error source. Sometimes they
are excluded from the synonym list due to the high
amount of false positive matches (e.g. C6, C7). Another
important reason for missing matches are ambiguous
gene names. If two or more different gene entries share a
synonym which is found in the text, the ProMiner system
Table 5: Evaluation of the database content in comparison to the Genetic Association Database (GAD).
Disease # Gene-disease 
associations in GAD
# Gene-disease 
associations in AIDB
# PubMed references 
listed in GAD
# PubMed references 
retrieved in AIDB
multiple sclerosis 57 84% (48/57) 82 73% (60/82)
Graves' disease 14 100% (14/14) 27 66% (18/27)
Addison's Disease 2 100% (2/2) 3 100% (3/3)
sarcoidosis 10 100% (10/10) 13 69% (9/13)
myasthenia gravis 6 66% (4/6) 8 38% (3/8)
alopecia areata 4 75% (3/4) 4 75% (3/4)
Crohn's Disease 14 93% (13/14) 29 93% (27/29)
Psoriasis 16 94% (15/16) 30 73% (22/30)
Ulcerative Colitis 11 90% (10/11) 16 81% (13/16)
Behcet's Disease 8 100% (8/8) 20 85% (17/20)
Narcolepsy 4 100% (4/4) 7 86% (6/7)
Inflamatory bowel Disease 17 94% (16/17) 24 92% (22/24)
Average - 91% - 78%
The evaluation results of the AIDB content using gene disease associations referenced in the GAD for the diseases 'multiple sclerosis' and 'Graves' 
disease' as well as 10 randomly selected diseases are shown. Column 1 lists the number of gene-disease associations extracted out of the GAD 
database. Column 2 shows the number of these associations found in the AIDB. Column 3 lists the number of PubMed references in GAD and 
column 4 lists the number of correctly retrieved PubMed references in the AIDB.BMC Bioinformatics 2006, 7:325 http://www.biomedcentral.com/1471-2105/7/325
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does only show the match if another synonym from the
same gene entry is found in the abstract. As an example we
discuss the entry of LRP associated to multiple sclerosis in
GAD. The corresponding link to Entrez Gene shows the
entry 4035 (LRP1; low density lipoprotein-related protein
1). With the automatic system we did not find this associ-
ation. The corresponding abstract [30] contains the rele-
vant phrase 'A2M and its receptor low-density lipoprotein
receptor-related protein (LRP)'. In Entrez Gene there are 4
gene entries with LPR as synonym (e.g. also 3921: laminin
receptor 1; 5786: R-PTP alpha) and more than 10 entries
contain the term 'low density lipoprotein-related protein'
combined with a number in their name. Specialists can
understand which gene is meant because a synonym of
LPR1 is 'A2M receptor' but ProMiner and to our knowl-
edge also no other available system is able to resolve this
ambiguity. Tests in the BioCreAtIvE assessment (cf. table
3, fly) have shown that accepting also ambiguous matches
would lead to higher recall rates (+ 3% for the fly-bench-
mark) but would decrease precision (-9%) and also F-
score (-3%).
To evaluate the quality of the highest ranked genes for the
frequency based ranking as well as the RANK-factor based
ranking we manually analysed the 50 highest ranked
genes for multiple sclerosis in the MeSH setting (1,086
genes). In the left section of table 7 we evaluate the quality
of the genes and PubMed references that are in GAD as
well as in AIDB (cf. table 7, 1st and 2nd column). For the
RANK based method only 3 genes among the top 50 were
also in GAD. This is due to the fact that the RANK factor
favours associations with few PubMed references. Two of
the three PubMed references were correctly retrieved. For
the frequency based method 24 genes among the top 50
were also in GAD and 19 of the 24 PubMed references
were correctly retrieved (79%). In the right section of table
7 (column 3–6) we evaluate the genes and PubMed refer-
ences that are only in the AIDB. Here the precision of cor-
rectly retrieved PubMed references is 81% for the RANK
based method and 85% for the frequency based method.
Examples for new true associations are listed in column 5
of table 7. CCL5 is a beta-chemokine and has been
detected in brain lesions of multiple sclerosis patients. It
may serve as a genetic risk marker for MS [31]. Matrix Met-
alloproteinase 9 (MMP9) is involved in blood-brain bar-
rier (BBB) disruption in active multiple sclerosis [32]
whereas glial fibrillary acidic protein (GFAP) may have
prognostic value in multiple sclerosis [33]. False associa-
tions (cf. table 7, column 6) are mainly based on false rec-
ognition of gene names. Here the recognition of CD4 and
CD8A as gene names instead of cell types is the most fre-
quent error source. Automatic identification of such false
matches is not solved satisfactorily till now and such
names could only be recognised due to manual inspec-
tion.
In summary it could be shown that the top genes give the
researcher a fast overview about relevant genes with
acceptable error rates. About half of the genes that are
ranked with the frequency based method are also repre-
sented in the GAD and further relevant associations could
be detected. Using the RANK based method provides fur-
ther interesting candidate genes with an acceptable preci-
sion for PubMed references (81%).
Using MeSH terms does not add any additional false pos-
itive errors. We used the PubMed query interface to con-
struct the MeSH term-PMID association table. The
situation is different when using UMLS concepts. Here we
searched the title and abstract of the Medline entry using
concept terms and synonyms as provided by the UMLS.
The source of errors lies in the polysemy of the synonyms.
Synonyms which are highly ambiguous such as abbrevia-
tions like MS, RA, SLE etc. were excluded from the list to
limit the number of false positives.
An additional test illustrates the advantage of including
disease concepts which are not contained in the MeSH
vocabulary. For these diseases we can only provide the
associations from the disease concept table. As an exam-
ple we discussed the results for autoimmune hearing loss
and autoimmune hypophysitis. Table 8 shows the results
for autoimmune hypophysitis. For this concept the AIDB
lists 15 genes with 21 references. Inspecting the references
Table 6: Error analysis for false negative recognition.
Gene/Protein Recognition Disease Term 
Recognition
Not found in 
Abstract
Error Class Not in dictionary Ambiguousgene name Recognition error Not in dictionary
# Errors (%) 5 (33%) 4 (27%) 1 (6.7%) 4 (27%) 1 (6.7%)
Error Examples C6
C7
Tcr-beta-chain
FAS
LRP
PLP
PD-1
MS
The error analysis of not recognised associations shows different error classes for missing gene name recognition (columns 1,2,3) and missing 
disease term recognition (column 4). The first row shows the number of missed references as well as the percentage, the second row shows 
examples for the different error classes.BMC Bioinformatics 2006, 7:325 http://www.biomedcentral.com/1471-2105/7/325
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reveals that 17 of the 21 references are correct (81%). The
reason for the wrong references is listed in the last col-
umn. The results for autoimmune hearing loss are compa-
rable. For this concept 8 genes with 9 references were
retrieved and 7 references were correct (77%). These
examples show that even in the case of only a few refer-
ences the AIDB contains candidate genes with an accepta-
ble precision.
Discussion
Considering the large number of autoimmune diseases
and the different medical faculties involved, it is impossi-
ble for a single researcher to get an overview of the genes
already studied. Suppose a researcher is performing a
microarray study for a specific autoimmune disease, i.e.
multiple sclerosis. Analysis of differential gene expression
reveals a list of several candidate genes. Some of them are
known to the researcher and well-discussed in the litera-
ture. Others are new in this context. For instance, the offi-
cial gene name ITGA4 is only mentioned twice in context
of multiple sclerosis, but searching for all names listed in
the ProMiner dictionary retrieves 52 PubMed abstracts
containing different synonyms of ITGA4 (integrin alpha
4, CD49d, VLA-4, alpha 4 subunit of VLA-4 receptor). This
is a time- consuming and tedious job where the usage of
the AIDB can save a lot of time.
We suppose that the researcher knows the genes for his/
her own field of research fairly well, lets say alopecia
areata, an autoimmune skin disease. But it is very unlikely
that the same researcher, probably a dermatologist, also
knows the scientific literature in the area of pancreatitis,
which is the subject of gastroenterologists. Following the
hypothesis that different autoimmune diseases share sim-
ilarities at the genomic level, it is a valuable service to pro-
vide researchers with candidate genes that were already
investigated in another autoimmune disease. A major
objective of the AIDB is to serve as an alternative, much
more effective way of literature search in the context of
autoimmune diseases and genes. It is not a database of
actual gene-disease associations.
One of the major problems that remains, is the problem
of polysemy. Polysemy is the ambiguity of an individual
word or phrase that can be used (in different contexts) to
express two or more different meanings. Gene or protein
names often consist of acronyms of a complicated long
form (e.g. ACE = angiotensin converting enzyme, CA2 =
carbonic anhydrase 2). ACE does have 158 different long
forms beside the enzyme long form which we store in an
acronym dictionary. We could ignore the ACE matches in
the ProMiner recognition if we find one of these other
long forms, otherwise we keep the match. If the long
forms of acronyms are not listed in our acronym diction-
ary this method fails. Furthermore we have no disam-
biguation strategies if the long form is not available in the
text. Another error source is the use of disease names as
gene and protein names. Since we found a higher rate of
these names in the evaluation for a new dictionary version
we have to include strategies for the automatic removal of
these names in the next version. Very short names like C6
and C7 as an example for gene names or MS as an example
for a disease name are often highly ambiguous and are
used in different contexts without using long forms. Here
we have two opportunities: Either we can drop every ref-
erence without a long form, which will result in a high
precision but a lower recall, or we can keep the reference
and accept a lower precision for the sake of a higher recall.
For names with high frequencies in the Medline corpus we
opted for the first possibility to drop all matches. For all
other names we accept the possibility of false matches to
ensure higher recall. The error analysis showed a lower
retrieval rate due to the above mentioned examples which
were excluded because of their ambiguous meaning. Fur-
thermore this evaluation shows that such a strategy
reaches an average retrieval rate of 78% compared to the
Table 7: Evaluation of the database content for the top 50 genes in multiple sclerosis.
AIDB and GAD Genes and PubMed references only in AIDB
Ranking Method # MS associated 
Genes
# correctly 
retrieved 
PubMed 
references
# MS associated 
Genes
# correctly 
retrieved 
PubMed 
references
Examples True 
Recognition
Examples False 
Recognition
RANK based 
Top 50
3/50 67% (2/3) 47/50 81% (38/47) MMP27, IFNA16, 
ADAMTS14
IBD2, Bw3, ABHs, 
THADA
Frequency 
based Top 50
24/50 79% (19/24) 26/50 85% (22/26) CCL5, MMP9, 
GFAP, CCL2, 
VCAM1, NOS2A
CD4, CD8A, 
CD86, CD25, 
CD28, CDR3
Evaluation of the quality of the 50 highest ranked genes in multiple sclerosis for the RANK (first row) and the frequency (second row) based 
methods. The number of genes that are also in GAD (1st column) and the number of correctly retrieved PubMed references (2nd column) are listed 
in the left part of the table. The right part (column 3–6) contains the results for the genes that were exclusively found in AIDB. Examples for true 
recognition are given in column 5 and examples for false recognition are given in column 6.BMC Bioinformatics 2006, 7:325 http://www.biomedcentral.com/1471-2105/7/325
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entries of the GAD database. Additionally, we found a
high rate of new disease-gene associations which occur
only in the AIDB. Here a short evaluation of the highest
ranking additional matches showed a precision rate of
(81–85%) for multiple sclerosis (cf. table 7). With these
results we were able to show that the AIDB enables
researchers to get an overview of disease-gene associations
with a few mouse clicks and reasonable recall and preci-
sion rates.
A strong limitation of the database is the missing extrac-
tion of the concrete relationships between the diseases
and the genes. Currently we do not, for example, distin-
guish between positive and negative statements. This
means that the co-occurrence of CARD15 and psoriasis in
"Psoriatic arthritis and CARD15 gene polymorphisms: no
evidence for association in the Italian population."
(PMID:15140210) adds to the positive number of co-
occurrences. The same is true for vague statements accord-
ing to the pattern "Our results suggest a role of gene x in
disease y". Having said this, we emphasise that the pri-
mary use case is navigating the autoimmune disease liter-
ature.
Related work
With the ever growing volumes of literature it is becoming
more and more essential to apply intelligent methods to
extract useful information embedded in literature data-
bases. In the past few years a number of tools and websites
have emerged that aim to assist in this task. To the best of
our knowledge, there is no tool or database that provides
the same information like the AIDB. Here we briefly
review some of the related work.
LitMiner [34] is a literature data-mining tool that assists in
the identification of gene regulation key players related to
a user defined set of key terms within PubMed abstracts.
Relationships can be predicted in four categories (genes,
chemical compounds, diseases and tissues). The basic
underlying method is that of term co-occurrences. Addi-
tionally, an overrepresentation score is calculated to filter
out the most relevant documents. To allow a curation of
the LitMiner predicted relations, the tool is combined
with WikiGene, a curation system that applies similar
ideas like the Wikipedia Project [35]. Although the scope
of LitMiner is much broader in the sense that the diseases
are not restricted to autoimmune diseases and that differ-
ent categories are integrated, the tool is currently not use-
ful in the area of autoimmune diseases. The LitMiner
Database currently contains 2,225 diseases, but covers
only a fraction of the autoimmune diseases in the AIDB.
CGMIM is a software tool that identifies genetically-asso-
ciated cancers and candidate genes [36]. This application
Table 8: Evaluation of the database content for autoimmune hypophysitis.
Gene Symbol # PMIDs in AIDB Reference correct? PMID Comment
PRL 4 Y 11683401
Y 6325687
Y 3923349
Y 16392184
POMC 3 Y 11683401
Y 2840382
Y 1310997
GNRH1 2 Y 3923349
Y 2840382
CD4 1 N 15493593 CD4 T cell recognised
CYP19A1 1 Y 15493593
COL14A1 1 N 16425001 "und" recognised as 
synonym
INA 1 Y 15234547
LY75 1 Y 15493593
CTLA4 1 Y 16224277
PTPRC 1 Y 15493593
TG 1 Y 1310997
AGMX2 1 N 15963060 "with growth hormone 
deficiency" as synonym
TNFRSF11B 1 Y 15493593
TNFRSF25 1 N 7800142 DR3 recognised as 
synonym
TPO 1 Y 1310997
Results for autoimmune hypophysitis. The term "autoimmune hypophysitis" is not in the MeSH vocabulary. 81% of the documents were correctly 
retrieved.BMC Bioinformatics 2006, 7:325 http://www.biomedcentral.com/1471-2105/7/325
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also uses text-mining and term co-occurrence as a basis for
the identification process but the source to be mined is the
Online Mendelian Inheritance in Man (OMIM) database.
This database has the advantage that it is a manually
curated database based on information reported in the
scientific literature. It therefore has a particularly high
quality. For autoimmune diseases this approach is not fea-
sible because there are only few autoimmune diseases that
are mentioned in OMIM.
The Genetic Association Database (GAD) [37] is a pub-
licly available NIH based database of published gene
based genetic association studies which contains records
of over 5,000 human genetic association studies. This
database is curated by experts and therefore has a high
quality. The complete content can be downloaded and
was used in the evaluation section. In a future version of
our database we plan to provide links to the data relevant
to autoimmune diseases.
G2D [38] is a database of candidate genes for mapped
inherited human diseases. The authors have developed a
score system that links genes to diseases based on litera-
ture associations of MeSH-D and MeSH-C terms as well as
GO functional terms. Due to missing entries for many
proteins in the MeSH terms also many gene-disease asso-
ciations can not be provided with such a method.
Hofmann and Schomburg [39] describe a system where
they used co-occurrence of UMLS concepts to assign dis-
eases to enzyme classes in the BRENDA database. The sys-
tem uses the MetaMap program to identify disease-related
concepts by their semantic fields in the UMLS ontology. A
support-vector-machine was used to filter out false posi-
tives based on their semantic fields. The system yields a
precision of 92% and a recall of 50%.
Future directions
In the current version the construction principles are
reflected in the limitation to gene disease associations and
in the flat hierarchy of the disease list. There are several
directions in which we would like to enhance the AIDB.
One way to improve the usability is to introduce a hierar-
chical structure of disease classes, e.g. Graves' disease is an
autoimmune thyroid disease, and allow creative group-
ings like antibody mediated diseases, T cell mediated dis-
eases, organ specificity, systemic diseases etc. In its next
version ProMiner will include protein complex and family
names which will expand the coverage to a larger area of
names. One other possible expansion is the inclusion of
further biomedical entities like drugs, pharmacological
substances, environmental factors or polymorphisms.
Approximately one-third of the risk of developing an
autoimmune disease can be attributed to hereditary fac-
tors; the remainder is thought to be associated with non-
inherited conditions. The first version of the autoimmune
database concentrates on gene-disease associations sim-
ply because the environment-disease link or rather the
gene-disease-environment link is poorly understood as of
yet. There are hardly any publications about environmen-
tal triggers and there are only a handful of known environ-
mental associations. Data in this area is very sparse.
Covering all suspected environmental triggers would of
course be a very useful and laudable aim, but it would
require extensive literature research by domain experts or
at least an ontology of environmental triggers, that could
be used for literature mining.
For the chemical entity side several very interesting data-
bases were developed in the past few years, e.g. Chemical
Entities of Biological Interest (ChEBI) [40] and DrugBank
[41,42]. The former lists, as the name suggests, chemical
entities that have an influence on biological processes, the
latter concentrates on drugs and substance used for drug
development. Using this information we could build a co-
occurrence matrix similar to the co-occurrence of gene-
disease links.
The greatest potential for improvement lies in some kind
of ranking of the Medline references. Scanning several
hundred references is not practical for the user. It is very
desirable to present important or relevant abstracts first.
These improvements would require the introduction of
text classification methods to analyse the abstracts at a
deeper level. Also, the kind of the gene-disease relation-
ship would be very informative. This also requires a
deeper analysis of the abstracts. A first step in this direc-
tion would be the analysis of the abstracts at the sentence
level. The detection of negative associations will be our
first focus. Examining the GAD one can see that 38% of
the entries for multiple sclerosis are references for negative
associations, 34% for positive associations and 28% are
not classified. Sorting after positive or negative associa-
tions will therefore be a valuable feature. Additional work
will also improve the possibilities of searching the data-
base. Here the Gene Ontology [43] can be used to index
the database. This would allow users to use Gene Ontol-
ogy terms to search the database. Finally, it is desirable to
optimise the database to gain lower response times.
Conclusion
To the best of the authors knowledge the AIDB is the first
literature-based database that provides gene-disease rela-
tionships in the context of all known or suspected autoim-
mune diseases. In the current version the AIDB can be
used as a tool for investigating possible gene-disease asso-
ciations in the context of autoimmune diseases and navi-
gating the corresponding literature. Although such a
dynamically compiled database does not cover all textu-BMC Bioinformatics 2006, 7:325 http://www.biomedcentral.com/1471-2105/7/325
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ally available information (around 78% in recall) it pro-
vides a high amount of additional information with
reasonable precision (around 80%) compared to manu-
ally generated content. Due to the high ambiguity of gene
names and acronyms used in biomedical context the cor-
rect recognition of gene and protein names is the limiting
factor for the coverage of the database.
There are three major achievements in this application
that allow the comparison of gene sets related to autoim-
mune diseases on the basis of the published scientific lit-
erature:
1) Named entity recognition of gene and protein names
and the mapping to unique identifiers done by the
ProMiner System.
2) Unifying disease names by using UMLS Concepts and
MeSH terms
3) Easy to use user interface that allows to navigate the
database content and the original literature
Without a tool of this kind it would be very tedious if not
impossible to get an overview of this huge group of dis-
eases.
A database of this kind can be compiled in a semi-
dynamic way even with limited resources. The methods
and the software used to compile the database can easily
be adapted to compile databases for different contexts
such as cancer, allergic diseases or inflammatory diseases.
However, providing additional biological background
knowledge like the classification of the diseases or the
genes could greatly enhance the usability of the database.
Availability and requirements
The Autoimmune Disease Database is freely available for
non profit use under the URL http://www.uni-rostock.de/
aidb
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